Ana C. deCarvalho
- Cancer Research top 2%
- MicroRNA in disease regulation 6
- Cancer Genomics and Diagnostics 4
- Genetics top 2%
- Glioma Diagnosis and Treatment 19
- Developmental Neuroscience top 10%
- Oncology top 5%
- Cancer Cells and Metastasis 8
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 4
- Single-cell and spatial transcriptomics 3
-
- Nanoplatforms for cancer theranostics 7
-
- Nanoparticle-Based Drug Delivery 4
- Co-authors
- Tom MikkelsenSteven N. KalkanisChaya BrodieCunli XiangSusan FinnissLaila PoissonStephanie L. LomonacoJohn L. Teem
- Partner nations
- United StatesIsraelCanada
In The Last Decade
Ana C. deCarvalho
40 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 698
- Genetics 481
- Developmental Neuroscience 71
- Oncology 456
- Molecular Biology 1.1k
Countries citing papers authored by Ana C. deCarvalho
This map shows the geographic impact of Ana C. deCarvalho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana C. deCarvalho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana C. deCarvalho more than expected).
Fields of papers citing papers by Ana C. deCarvalho
This network shows the impact of papers produced by Ana C. deCarvalho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana C. deCarvalho. The network helps show where Ana C. deCarvalho may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ana C. deCarvalho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2022 | 16 | |
| 5 | 2021 | 14 | |
| 6 | 2021 | 144 | |
| 7 | 2018 | 5 | |
| 8 | 2018 | 84 | |
| 9 | 2018 | 176 | |
| 10 | 2014 | 28 | |
| 11 | 2014 | 129 | |
| 12 | 2014 | 46 | |
| 13 | 2014 | 123 | |
| 14 | 2013 | 36 | |
| 15 | 2013 | 36 | |
| 16 | 2009 | 24 | |
| 17 | 2007 | 13 | |
| 18 | 2005 | 40 | |
| 19 | 2005 | 28 | |
| 20 | 2002 | 90 |
About Ana C. deCarvalho
Ana C. deCarvalho is a scholar working on Genetics, Cancer Research and Developmental Neuroscience, having authored 44 papers that have together received 2.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (19 papers), Cancer Cells and Metastasis (8 papers), Nanoplatforms for cancer theranostics (7 papers), MicroRNA in disease regulation (6 papers), Nanoparticle-Based Drug Delivery (4 papers), Cancer Genomics and Diagnostics (4 papers), Epigenetics and DNA Methylation (4 papers) and Single-cell and spatial transcriptomics (3 papers). The work is most often cited by research in Cancer Research (698 citations), Genetics (481 citations) and Developmental Neuroscience (71 citations). Ana C. deCarvalho has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Tom Mikkelsen, Steven N. Kalkanis, Chaya Brodie, Cunli Xiang, Susan Finniss, Laila Poisson, Stephanie L. Lomonaco, John L. Teem, Félix Umansky and Lisa J. Gansheroff. Their work appears in journals such as Journal of Biological Chemistry, Nature Genetics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.